Medical Market Report

Global Influenza Diagnostics Market By Type (RIDT, RT-PCR, and Cell Culture), By Application (Hospitals, and POCT), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 134342
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Influenza Diagnostics Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global influenza diagnostics market is segmented on the basis of Type, Application and geography.
    The worldwide market for Influenza Diagnostics Market is expected to grow at a CAGR of roughly x.x% over the next ten years and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Influenza Diagnostics Market Scope:

    By type, the market is segmented into RIDT, RT-PCRand Cell Culture. By Application, the market is divided into Hospitalsand POCT. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, Enigma Diagnosticsand Focus Diagnostics.

    Key Market Segments

    Type

    RIDT
    RT-PCR
    Cell Culture

    Application

    Hospitals
    POCT

    Key Market Players included in the report:

    BD
    Abbott (Include Alere)
    Roche
    SIEMENS
    Analytik Jena
    Quidel
    Thermo Fisher
    Meridian Bioscience
    BioMerieux
    Sekisui Diagnostics
    Response Biomedical
    SA Scientific
    Enigma Diagnostics
    Focus Diagnostics

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Influenza Diagnostics Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Influenza Diagnostics Market, high-growth regions, and market drivers, restraints and also market chances.
    The analysis covers Influenza Diagnostics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Influenza Diagnostics Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Influenza Diagnostics Market together side their company profiles, SWOT analysis, latest advancements and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
    To know the Influenza Diagnostics Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Influenza Diagnostics sub-markets, depending on key regions (various vital states).
    To analyze Influenza Diagnostics Market concerning growth trends, prospects and also their participation in the entire sector.
    To examine and study the Influenza Diagnostics Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
    Primary worldwide Influenza Diagnostics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

  • Table Of Content 
    1. Influenza Diagnostics Market Introduction
    
1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    
2. Executive Summary
    
2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players
    
3. Global Influenza Diagnostics Market Overview
    
3.1. Influenza Diagnostics Market Dynamics
    
3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges
    
3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map
    
4. Global Influenza Diagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    
4.1. Global Influenza Diagnostics Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. RIDT
    
4.4. RT-PCR
    
4.5. Cell Culture
    
5. Global Influenza Diagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    
5.1. Global Influenza Diagnostics Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Hospitals
    
5.4. POCT
    
6. Global Influenza Diagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    
6.1. North America
    
6.1.1. North America Influenza Diagnostics Market: Regional Trend Analysis
    
6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    
6.2. Europe
    
6.2.1. Europe Influenza Diagnostics Market: Regional Trend Analysis
    
6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    
6.3. Asia-Pacific
    
6.3.1. Asia-Pacific Influenza Diagnostics Market: Regional Trend Analysis
    
6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    
6.4. Latin America
    
6.4.1. Latin America Influenza Diagnostics Market: Regional Trend Analysis
    
6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    
6.5. Middle East and Africa
    
6.5.1. Middle East and Africa Influenza Diagnostics Market: Regional Trend Analysis
    
6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Influenza Diagnostics Market Competitive Landscape, Market Share Analysis, and Company Profiles
    
7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. BD
    
7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments
    
7.4. Abbott (Include Alere)
    
7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments
    
7.5. Roche
    
7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments
    
7.6. SIEMENS
    
7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments
    
7.7. Analytik Jena
    
7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments
    
7.8. Quidel
    
7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments
    
7.9. Thermo Fisher
    
7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments
    
7.10. Meridian Bioscience
    
7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments
    
7.11. BioMerieux
    
7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments
    
7.12. Sekisui Diagnostics
    
7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments
    
7.13. Response Biomedical
    
7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments
    
7.14. SA Scientific
    
7.14.1. Company Overview
    
7.14.2. Financial Highlights
    
7.14.3. Product Portfolio
    
7.14.4. SWOT Analysis
    
7.14.5. Key Strategies and Developments
    
7.15. Enigma Diagnostics
    
7.15.1. Company Overview
    
7.15.2. Financial Highlights
    
7.15.3. Product Portfolio
    
7.15.4. SWOT Analysis
    
7.15.5. Key Strategies and Developments
    
7.16. Focus Diagnostics
    
7.16.1. Company Overview
    
7.16.2. Financial Highlights
    
7.16.3. Product Portfolio
    
7.16.4. SWOT Analysis
    
7.16.5. Key Strategies and Developments
    
8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.